Orange Book product · Generic (ANDA)
PYRIDOSTIGMINE BROMIDE
PYRIDOSTIGMINE BROMIDE
At a glance
Jun 28, 2022
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jun 28, 2022
4 yr ago
Today
Pharmaceutical detail
Active ingredient
PYRIDOSTIGMINE BROMIDE
Strength
30MG
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 040502
Product number
002
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PYRIDOSTIGMINE BROMIDE
- 2024PYRIDOSTIGMINE BROMIDEBrand (NDA)
NDA 217604 · AMNEAL
- 2003PYRIDOSTIGMINE BROMIDEBrand (NDA)
NDA 020414 · US ARMY
- —MESTINONBrand (NDA)
NDA 009830 · BAUSCH
- —REGONOLBrand (NDA)
NDA 017398 · SANDOZ
- —MESTINONBrand (NDA)
NDA 015193 · BAUSCH
- —MESTINONBrand (NDA)
NDA 011665 · BAUSCH
- —MESTINONBrand (NDA)
NDA 009829 · BAUSCH
- 2023PYRIDOSTIGMINE BROMIDEGeneric (ANDA)
ANDA 216512 · MSN
- 2022PYRIDOSTIGMINE BROMIDEGeneric (ANDA)
ANDA 212405 · MILLA PHARMS
- 2020PYRIDOSTIGMINE BROMIDEGeneric (ANDA)
ANDA 212702 · AMNEAL
- 2020PYRIDOSTIGMINE BROMIDEGeneric (ANDA)
ANDA 208797 · RISING
- 2019PYRIDOSTIGMINE BROMIDEGeneric (ANDA)
ANDA 211181 · MLV
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
